Celestial Biolabs (BOM:532871) YoY EBITDA Growth : -5.88% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Celestial Biolabs YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Celestial Biolabs's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -5.88%.

Celestial Biolabs's EBITDA per Share for the three months ended in Dec. 2023 was ₹-0.02.

Celestial Biolabs YoY EBITDA Growth Historical Data

The historical data trend for Celestial Biolabs's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celestial Biolabs YoY EBITDA Growth Chart

Celestial Biolabs Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

YoY EBITDA Growth

Get a 7-Day Free Trial

2.29

-140.57

97.33

-158.62

-60.67

Celestial Biolabs Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															32.00	-260.00	-288.24	-2.04	-5.88

Celestial Biolabs YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Celestial Biolabs's YoY EBITDA Growth for the fiscal year that ended in Mar. 2023 is calculated as:

	YoY EBITDA Growth (A: Mar. 2023 )
=	(EBITDA per Share (A: Mar. 2023 )	-	EBITDA per Share (A: Mar. 2022 ))	/	\| EBITDA per Share (A: Mar. 2022 ) \|
=	(-0.241	-	-0.15)	/	\| -0.15 \|
=	-60.67 %

Celestial Biolabs's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Jun. 2022 ))	/	\| EBITDA per Share (Q: Jun. 2022 )) \|
=	(-0.018	-	-0.017)	/	\| -0.017 \|
=	-5.88 %

Celestial Biolabs YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Celestial Biolabs's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Celestial Biolabs (BOM:532871) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celestial Biolabs Ltd (BOM:532871) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot No. 59, Road No 12, TSIIC Tech Park, IDA Nacharam, Hyderabad, TG, IND, 500076

Website

http://www.celestialbiolabs.com

Celestial Biolabs Ltd is an India based biopharmaceutical company. It is engaged in the business activity producing and supplying of the biotechnological products. The company offers herbal, feed supplement and nutraceutical products. The proprietary herbal products of the group include BIOVITA, CADALMIN GAE, CEL-DIGEST, BIOLIV, RHUMACEL, CEL-CLEAR, Trem Plus, O-KOF, BIOPOWER GOLD, BIO-DNORM, DERMACEL, GYNOCEL, HEALTHONE, RELIFIN, and C-KAPS. The organization formulates and manufactures Ayurvedic proprietary products for the Indian market.

Celestial Biolabs (BOM:532871) Headlines

No Headlines